𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroendocrine differentiation in prostate cancer

✍ Scribed by Jingwen Wang; Yang Yao

Publisher
Springer
Year
2008
Tongue
English
Weight
77 KB
Volume
7
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

STAT3 mediates IL-6-induced neuroendocri
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells
✍ Spiotto, Michael T.; Chung, Theodore D.K. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 653 KB

## Background: In the human prostate cancer cell line lncap, interleukin (il)-6 has been shown to regulate both growth and neuroendocrine (ne) differentiation. we recently observed that il-6 mediated growth arrest in lncap by activating stat 3. since differentiation and growth arrest are often asso

Modulation of neuroendocrine differentia
Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2
✍ Diaz, Miguel; Abdul, Mansoor; Hoosein, Naseema πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 2 views

Neuroendocrine differentiation in prostate cancer has received much attention recently because it has been found to be associated with androgen independence and shortened patient survival in some studies. We have investigated the effect of the cytokines interleukin-1 (IL-1), IL-2, and IL-6 on the ex

Regressive changes and neuroendocrine di
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
✍ Ahlgren, G.; Pedersen, K.; Lundberg, S.; Aus, G.; Hugosson, J.; Abrahamsson, P.- πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 260 KB πŸ‘ 1 views

## BACKGROUND. We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3-month hormonal treatment. METHODS. Radical prostatectomy specimens from 103 patients, randomized to 3-month neoadjuvant LH-RH-analogue treatment (

Upregulation of manganese superoxide dis
Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells
✍ Isabel QuirΓ³s; Rosa M. SΓ‘inz; David Hevia; Olivia GarcΓ­a-SuΓ‘rez; Aurora Astudill πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 323 KB

## Abstract Despite improvements in diagnosis of advanced prostate cancer (PCa), treatment is not efficient and 5‐year survival is still low. Initially, the less abundant of cell types, neuroendocrine cells (NE), are involved in regulatory process but their physiological role is not fully understoo

Interleukin-6 inhibits the growth of pro
Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation
✍ Qingcai Wang; Dimitris Horiatis; Jacek Pinski πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 701 KB

## Abstract __In vitro__, the human prostate cancer (PCA) cell line LNCaP can be permanently transdifferentiated into a quiescent neuroendocrine (NE) phenotype by the cytokine interleukin‐6 (IL‐6). Recently, we have shown that the growth of prostate cancer cells is significantly suppressed when coc